Obinutuzumab for Treatment of Proliferative Lupus Nephritis in Severe Kidney Failure: A Report of Two Cases (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0777; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Discussion Obinutuzumab as induction therapy for patients with proliferative lupus nephritis with significant impairment of kidney function and GFR < 30 ml/min/1.73m2 shows favorable clinical and kidney outcomes. Follow-up at 6 months and one year is ongoing."
Clinical • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease
|
|
Nohelia María Ortuño Moreno; Sarai Ruth Barrientos Feria; Arisbeth Villanueva-Perez; Octavio Rene Garcia-Flores; Enzo Christopher Vasquez Jiménez
|